Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromitsu Imai

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|February 26, 2008
The recovery time-course of CYP3A after induction by St John's wort administrationHiromitsu Imai, Tsutomu Kotegawa, Kimiko Tsutsumi, et al.
Frontiers in Pharmacology|June 30, 2026
Water intake during drinking does not alleviate hangover symptomsHiromitsu Imai, Satoshi Kushio, Keiko Matsuura, et al.
Clinical and Experimental Pharmacology & Physiology|September 2, 2009
Pharmacokinetics and pharmacodynamics of low doses of midazolam administered intravenously and orally to healthy volunteersShingen Misaka, Shinya Uchida, Hiromitsu Imai, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 2, 2020
The μ-opioid receptor gene polymorphism 118A>G weakens the pharmacological action of buprenorphineHiromitsu Imai, Misaki Morita, Hajime Morita, et al.
The AAPS Journal|February 10, 2026
Utility of Modeling and Simulations in Drug Development: Contrasting Japan, US and UK Descriptions of PBPK Modeling from Package InsertsShinji Kudo, Hirokazu Wakuda, Ichiro Oikawa, et al.
The Journal of Dermatology|July 11, 2022
Pharmacokinetics of lanoconazole in human skin after repeated topical applicationHiromitsu Imai, Satoru Hashimoto, Ryo Ninomiya, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 30, 2019
Development of a simultaneous quantitation for short-, medium-, long-, and very long-chain fatty acids in human plasma by 2-nitrophenylhydrazine-derivatization and liquid chromatography-tandem mass spectrometryZhen Chen, Zijun Gao, Yue Wu, et al.
JMIR Formative Research|May 27, 2026
Fixed Versus Lottery Incentives for Promoting Engagement With a Cadence-Based Smartphone App: Randomized Crossover TrialKosuke Hayashi, Hiromitsu Imai, Ichiro Oikawa, et al.
Pharmacogenetics and Genomics|February 1, 2011
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humansJunko Imanaga, Tsutomu Kotegawa, Hiromitsu Imai, et al.
Journal of Pharmaceutical Sciences|June 4, 2015
An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug DevelopmentShinji Yamashita, Makoto Kataoka, Yuki Suzaki, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|February 26, 2008
The recovery time-course of CYP3A after induction by St John's wort administrationHiromitsu Imai, Tsutomu Kotegawa, Kimiko Tsutsumi, et al.
Frontiers in Pharmacology|June 30, 2026
Water intake during drinking does not alleviate hangover symptomsHiromitsu Imai, Satoshi Kushio, Keiko Matsuura, et al.
Clinical and Experimental Pharmacology & Physiology|September 2, 2009
Pharmacokinetics and pharmacodynamics of low doses of midazolam administered intravenously and orally to healthy volunteersShingen Misaka, Shinya Uchida, Hiromitsu Imai, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 2, 2020
The μ-opioid receptor gene polymorphism 118A>G weakens the pharmacological action of buprenorphineHiromitsu Imai, Misaki Morita, Hajime Morita, et al.
The AAPS Journal|February 10, 2026
Utility of Modeling and Simulations in Drug Development: Contrasting Japan, US and UK Descriptions of PBPK Modeling from Package InsertsShinji Kudo, Hirokazu Wakuda, Ichiro Oikawa, et al.
The Journal of Dermatology|July 11, 2022
Pharmacokinetics of lanoconazole in human skin after repeated topical applicationHiromitsu Imai, Satoru Hashimoto, Ryo Ninomiya, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 30, 2019
Development of a simultaneous quantitation for short-, medium-, long-, and very long-chain fatty acids in human plasma by 2-nitrophenylhydrazine-derivatization and liquid chromatography-tandem mass spectrometryZhen Chen, Zijun Gao, Yue Wu, et al.
JMIR Formative Research|May 27, 2026
Fixed Versus Lottery Incentives for Promoting Engagement With a Cadence-Based Smartphone App: Randomized Crossover TrialKosuke Hayashi, Hiromitsu Imai, Ichiro Oikawa, et al.
Pharmacogenetics and Genomics|February 1, 2011
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humansJunko Imanaga, Tsutomu Kotegawa, Hiromitsu Imai, et al.
Journal of Pharmaceutical Sciences|June 4, 2015
An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug DevelopmentShinji Yamashita, Makoto Kataoka, Yuki Suzaki, et al.
Pageof 3